Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Ariz. Gov. Signs Bills Increasing Abortion Restrictions, Updating Existing Statutes
Arizona Gov. Jan Brewer (R) on Monday signed into law a bill (HB 2564) that mandates a 24-hour waiting period and in-person counseling with a doctor before women can receive abortion care, the AP/Yahoo! News reports. The law requires doctors to list risks and alternatives and describe the fetus"s probable characteristics. It also makes an existing parental consent law more restrictive for minors seeking abortion care and allows health care workers to refuse to dispense emergency contraception on moral or religious grounds.Planned Parenthood Arizona said the measure "creates barriers, increases costs and denies access to services and providers to women who seek abortion care." Bryan Howard, the affiliate"s president, said, "Women will be forced to delay their care, in turn increasing their health risks." In signing the measure, Brewer "set a new course" from former Gov. Janet Napolitano (D), who vetoed all bills that restricted abortion rights during her six years as governor, the AP/Yahoo! News reports.Brewer Signs Law Revising "Partial-Birth Abortion" Ban Brewer also signed legislation (HB 2400) that revises an Arizona law banning so-called "partial-birth" abortion except when the procedure is necessary to save the woman"s life. A federal judge in October 1997 ruled that a state law banning the procedure was unconstitutional, but the Supreme Court in 2007 upheld a similar federal law. The new law is intended to align the 1997 state law with the federal statute, according to the AP/Yahoo! News.The new law specifies a punishment of up to two years in prison. It allows a doctor charged under the law to seek a hearing before a state regulatory board to determine if the doctor"s actions were necessary to save the woman. Advocates of the bill say that it will allow local authorities to enforce the ban on the procedure (Davenport, AP/Yahoo! News, 7/13).
generic viagra online
Researchers Make Progress Toward Early Identification Of Muscular Dystrophy
The saying "Knowing is half the battle" is never more true than when discussing early treatment of disease. Muscular dystrophy is one such disease where patients can benefit from early treatment. Now, new research is moving doctors and scientists closer to disease diagnosis in advance of patient symptoms.
News of the day
Colorado State University Veterinarians Offer Pet Care Tips During Summer Months
The following are helpful tips to pet owners offered by veterinarians at Colorado State University?s Veterinary Teaching Hospital. The paragraphs can be used alone as filler or in a group as a set of tips. If you need additional information, please contact Dell Rae Moellenberg at 970-491-6009 or DellRae.Moellenberg@colostate.edu. If you?d like to attribute the information, please attribute it to Colorado State University?s College of Veterinary Medicine and Biomedical Sciences.
Medical Devices

UC Davis Researchers Develop New Test For Fragile X Syndrome

Researchers at UC Davis have developed a new test that will measure the protein deficit responsible for fragile X syndrome - the single-most common cause of intellectual impairment and the most-commonly inherited cause of autism. The test, described in a study appearing online in the July 2009 issue of The Journal of Molecular Diagnostics, is the first to measure an individual"s level of the fragile X mental retardation 1 (FMR1) protein. Fragile X syndrome is the result of low levels of the FMR1 protein, which is known to play a role in communication between nerve cells. In patients with fragile X syndrome, a sequence of one cytosine and two gaunine bases (CGG) in the FMR1 gene, repeated 10 to 40 times in normal individuals, is expanded to more than 200 repeats, leading to gene silencing and decreasing levels of the protein. Study senior author Paul J. Hagerman, a professor in the Department of÷  Biochemistry and Molecular Medicine in the UC Davis School of Medicine and director of the NeuroTherapeutics Research Institute (NTRI), said the study describes "a powerful tool to further investigate the relationship between FMR1 and the broad range of clinical involvement in fragile X syndrome." Existing tests for fragile X syndrome determine the presence of the fragile X mutation by measuring the number of CGG repeats in the gene. The new test, called ELISA - for enzyme-linked immunosorbent assay - measures the level of FMR1 protein (FMRP) in individuals with the mutated gene. "This test is quantitative and we think it will correlate with clinical involvement including the cognitive and behavioral problems that are part of fragile X syndrome. In addition, some carriers may be mildly deficient in this protein and we will see how this deficit relates to the emotional and attention problems that some experience" says Randi Hagerman, professor of pediatrics, and director of the Fragile X Treatment and Research Center at the UC Davis M.I.N.D. Institute. In addition to fragile X syndrome, deficits in FMRP are linked to a variety of disorders, including developmental delay, behavioral difficulties, anxiety and attention-deficit /hyperactivity disorder (ADHD). Altered FMRP levels may also contribute to clinical involvement in children who carry smaller numbers of ("premutation") CGG expansions, and to the neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), and primary ovarian insufficiency. Other study authors include Christine Iwahashi, Dag Yasui and Greg Mayeur of the Department of Biochemistry and Molecular Medicine in the UC Davis School of Medicine; Randi Hagerman and Flora Tassone of the UC Davis M.I.N.D. Institute; Danh Nguyen of the UC Davis Department of Public Health Sciences; and George Parrott of the CSU Sacramento Department of Psychology. The study was funded by grants from the National Institutes of Health Interdisciplinary Research Consortium, the National Center for Research Res and the UC Davis M.I.N.D. Institute. UC Davis M.I.N.D. Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009